Human Ebola virus infection results in substantial immune activation

Proceedings of the National Academy of Sciences of the United States of America
Anita K McElroyRafi Ahmed

Abstract

Four Ebola patients received care at Emory University Hospital, presenting a unique opportunity to examine the cellular immune responses during acute Ebola virus infection. We found striking activation of both B and T cells in all four patients. Plasmablast frequencies were 10-50% of B cells, compared with less than 1% in healthy individuals. Many of these proliferating plasmablasts were IgG-positive, and this finding coincided with the presence of Ebola virus-specific IgG in the serum. Activated CD4 T cells ranged from 5 to 30%, compared with 1-2% in healthy controls. The most pronounced responses were seen in CD8 T cells, with over 50% of the CD8 T cells expressing markers of activation and proliferation. Taken together, these results suggest that all four patients developed robust immune responses during the acute phase of Ebola virus infection, a finding that would not have been predicted based on our current assumptions about the highly immunosuppressive nature of Ebola virus. Also, quite surprisingly, we found sustained immune activation after the virus was cleared from the plasma, observed most strikingly in the persistence of activated CD8 T cells, even 1 mo after the patients' discharge from the hospital. These results...Continue Reading

References

Mar 4, 2000·Laboratory Investigation; a Journal of Technical Methods and Pathology·T W GeisbertP B Jahrling
Oct 12, 2000·Proceedings of the National Academy of Sciences of the United States of America·C F BaslerP Palese
May 2, 2002·Clinical and Experimental Immunology·S BaizeE Mavoungou
Mar 11, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Siddhartha MahantyBali Pulendran
May 31, 2007·The Journal of Experimental Medicine·Melissa L PrecopioRichard A Koup
Dec 6, 2007·The Journal of Infectious Diseases·Jonathan S TownerStuart T Nichol
Aug 22, 2009·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Christopher F Basler, Gaya K Amarasinghe
Nov 26, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Rama S AkondyRafi Ahmed
Dec 24, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Steven B BradfuteSina Bavari
Jul 29, 2011·Journal of Virology·Therese LindgrenNiklas K Björkström
Mar 1, 2014·Expert Review of Vaccines·Andrea Marzi, Heinz Feldmann
Aug 30, 2014·Nature·Xiangguo QiuGary P Kobinger
Sep 28, 2014·Journal of Autoimmunity·Aftab A Ansari
Oct 23, 2014·The New England Journal of Medicine·Benno KreuelsStefan Schmiedel
Nov 13, 2014·The New England Journal of Medicine·G Marshall LyonUNKNOWN Emory Serious Communicable Diseases Unit

❮ Previous
Next ❯

Citations

Nov 20, 2015·The Journal of Infectious Diseases·Brian H BirdChristina F Spiropoulou
Dec 15, 2015·Science Translational Medicine·Donata MedagliniUNKNOWN VSV-Ebovac Consortium
Jan 27, 2016·Emerging Infectious Diseases·John R ChancellorOlga M Cerón
Jan 5, 2016·The Lancet Infectious Diseases·John G MattiaSharmistha Mishra
Nov 10, 2015·The Journal of Clinical Investigation·Simone LaniniUNKNOWN INMI-EMERGENCY EBOV Sierra Leone Study Group
Oct 7, 2015·Nature Reviews. Microbiology·Ilhem MessaoudiChristopher F Basler
Jul 15, 2015·Current Opinion in Immunology·Ilhem Messaoudi, Christopher F Basler
May 30, 2015·Cell Death and Differentiation·L FalascaM Piacentini
Jul 6, 2015·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·David S Fedson, Ole Martin Rordam
Apr 9, 2015·Proceedings of the National Academy of Sciences of the United States of America·Judith N Mandl, Mark B Feinberg
Nov 13, 2015·The New England Journal of Medicine·Steven YehIan Crozier
May 9, 2016·Enfermedades infecciosas y microbiología clínica·Marta ArsuagaAna Vázquez González
May 10, 2016·Nature Medicine·Andrew S IshizukaRobert A Seder
Mar 30, 2016·The Lancet Infectious Diseases·Pauline VetterDaniel G Bausch
Jun 23, 2016·The New England Journal of Medicine·Johan van GriensvenUNKNOWN Ebola-Tx Consortium
Oct 16, 2015·Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases·Manas R DikhitPradeep Das
Jul 30, 2016·The Journal of Infectious Diseases·Sophie J SmitherMark Stephen Lever
Jun 30, 2016·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Anita K McElroyChristina F Spiropoulou
Aug 23, 2016·Human Vaccines & Immunotherapeutics·Sara Viksmoen WatleJohn-Arne Røttingen
May 6, 2016·Annual Review of Genomics and Human Genetics·Angela L Rasmussen
Dec 9, 2016·PLoS Pathogens·Ndongala Michel LubakiAlexander Bukreyev
Mar 2, 2016·PLoS Neglected Tropical Diseases·Julii BrainardPaul Hunter
Jan 24, 2017·Nature Reviews. Immunology·Joseph B PrescottSonja M Best
Dec 14, 2016·Annual Review of Pathology·Laura BaselerDavid M Morens
Dec 17, 2015·Therapeutic Advances in Vaccines·Saranya Sridhar
Oct 30, 2015·Viruses·Sandra L Bixler, Arthur J Goff
Dec 24, 2017·Biotechnology Journal·Simona AnticoliMaurizio Federico
Nov 8, 2017·The Journal of Infectious Diseases·Sook-San WongUNKNOWN SHIVERS Investigation Team
Oct 12, 2017·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Lilin LaiUNKNOWN Emory Zika Patient Study Team
Apr 13, 2018·PLoS Pathogens·Patrick YounanAlexander Bukreyev
Feb 13, 2018·Journal of Leukocyte Biology·Andrew W Taylor, Tat Fong Ng
Nov 1, 2016·Journal of Virology·Anmol ChandeleKaja Murali-Krishna
Aug 8, 2015·Antimicrobial Agents and Chemotherapy·Azizul HaqueJoel Blondiaux
Sep 28, 2017·MBio·Patrick YounanAlexander Bukreyev
Jan 27, 2019·Vaccines·Federico Perdomo-CelisJuan C Zapata
Feb 28, 2018·Nature Communications·Zhongfang WangKatherine Kedzierska
Jan 8, 2019·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Govindakarnavar ArunkumarStuart T Nichol

❮ Previous
Next ❯

Related Concepts

Related Feeds

B cell Differentiation

Depending on the signal received through the B cell receptor and other receptors, B cells differentiate into follicular or marginal zone B cells. Here is the latest research pertaining to this differentiation process.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Related Papers

Proceedings of the National Academy of Sciences of the United States of America
Judith N Mandl, Mark B Feinberg
The Journal of Immunology : Official Journal of the American Association of Immunologists
Michael J Fuller, A J Zajac
© 2021 Meta ULC. All rights reserved